Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leflunomide in Idiopathic Pulmonary Hemosiderosis
NCT05937191Phase 2Recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Jun 2023
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of leflunomide in Idiopathic Pulmonary Hemosiderosis (IPH), sponsored by Sun Yat-sen Memorial Hospital. Started Jun 2023; status: recruiting.
02
Drugs
leflunomide
03
Conditions
Idiopathic Pulmonary Hemosiderosis (IPH)
Beyond the preview
Go deeper on NCT05937191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05937191.